Proximate cord insertions (PCI) is one of the abnormal umbilical cord insertion in monochorionic (MC) twins, when the distance between the cord insertions is less than < 4 cm. PCI in MC diamniotic (DC) placentas is quite rare whereas in MC monoamniotic (MA) placentas is quite common. We presented two cases of monochorionic (MC) twins with diamniotic and monoamniotic placentas. Case: A 26 y.o. woman (G2P0) with MCDA pregnancy by spontaneous conception. US scan at 12 w identified PCI with superficial anastomoses. It was non-complicated pregnancy with Caesarean delivery at 36 +5 weeks due to severe oligohydramnios of 2nd twin. Birth weight of 1st and 2nd twin was 2600 g and 2400 g. Apgar score was 8/8 and 8/8 in 1 and 5 minutes. The placental examination confirmed that the umbilical cords were very near to each other with one anastomose between them. Case 2: A 31 y.o. woman (G6P2) with MCMA twin pregnancy by spontaneous conception. PCI was identified at 13-14 w. The cord entanglement with the knot was visualised at 28 w scan. The pregnancy progressed uneventfully with Caesarean delivery at 38 w. Birth weight of 1st and 2nd twin was 3100 g and 3470 g. Apgar score was 8/9 and 9/9 in 1 and 5 minutes. The distance between cord insertions was 2.8 cm and the presence of cord entanglement with the knot was confirmed at placental examination.
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MCMA twin pregnancy accounts for 1-2% of all twin pregnancies and requires close monitoring due to risk of fetal death and cord entanglement. We report a case of MCMA twin pregnancy with discordant anomalies in both fetuses.
A 37 year old G3P2 woman, followed at the fetal medicine clinic with MCMA twin pregnancy since 14 weeks of gestation. The woman had no significant past medical or surgical history and had previous two spontaneous vaginal deliveries at term with no complications. Her anomaly scan at 21 weeks gestation showed multiple amniotic bands with normal parameters for both twins and normal amniotic fluid volume. Twin A was diagnosed with a small VSD, partial amelia of both lower limbs and enlarged bladder but with normal kidneys. Twin B with mildly dilated aortic arch but the rest was normal. Fetal echo was performed confirming the findings. The woman was counselled and offered amniocentesis but she declined. She was followed up closely every 2 weeks until 28 weeks where she was admitted in the antenatal word for preterm premature rupture of membranes. She was planned for an elective Caesarean section at 33 weeks gestation but she went into spontaneous labour and had heavy vaginal bleeding. An emergency Caesarean section was performed and confirmed placental abruption with the presence of cord entanglement. The babies were born alive with good Apgar scores and birth weight of 1.6 and 1.8 kg. Both twins were admitted in the neonatal ICU on CPAP. Examination including echo confirmed the antenatal findings with large PDA and small VSD for twin A and small PDA for twin B. Unfortunately on Day 5 of life twin B was desaturating and showed signs of sepsis. The neonate was intubated but died on the same day due to sepsis and pulmonary hemorrhage. Twin A was discharged in a stable condition after 4 weeks and was given a follow-up with orthopedic for management of the lower limb anomaly. EP20.20 ''Two weeks' younger sister'': a case of monopaternal superfecundation after clomifene citrate ovulation induction M. Ciebiera, G. Jakiel
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Superfecundation is the fertilisation of two or more ova from the same menstrual cycle by sperm from separate sexual intercourses. Ovulation is suspended during pregnancy in major of cases to prevent further fertilisation and to increase the chances of a full-term pregnancy. The time window when ova are able to be fertilised is small, that is why most superfecundations happens within hours of the first fertilisation with ova released during the same cycle. There are two types of superfecundation: monopaternal (one father), heteropaternal (two or more fathers).
We present a case of 30 years old primipara in a twin pregnancy after the clomifene citrate ovulation induction. Women was diagnosed with a 15 mm Crown-rump length difference between twins in 10th week of gestation (I twin 34 mm, II twin 20 mm). The 11+0 -13+6 week scan confirmed the two week disproportion between fetuses and two different placentas. Patient did not decide to perform prenatal invasive diagnostics to exclude the potential chromosomal abnormalities, due to the fear of complications. Karyotyping after birth revealed two normal female karyotypes (46, XX). Smaller twin was diagnosed with left superior vena cava, no more anatomical variation or abnormalities were found in subsequent scans. Patient was treated as an atypical case of selective intrauterine growth restriction, examinations were performed every two weeks to control the proper fetal growth. During the 36th week of gestation patients preterm premature rupture of membranes occurred, and because of the transverse position of the second twin a Caesarean section was performed. Neonates were born in good overall condition, the weight difference between them was counted as 630g (I twin 2180g, II twin 1550g). Further examinations (e.g. neurological and ophthalmological revealed that the second twin was two weeks less matured and excluded intrauterine growth restriction features. Objectives: To evaluate third trimester fetal cardiac morphometry and function in monochorionic diamniotic (MCDA) twins with TTTS that survived after fetal therapy. Methods: Prospective case-control study conducted between January 2015 and December 2016 at our tertiary centre. We included 55 MCDA fetuses that survived after fetal surgery (30 recipients and 25 donors). We compared this group with 60 uncomplicated MCDA fetuses. Mean gestational age at surgery and third trimester evaluation were 19.1±2.2 and 29.4±1.4 weeks respectively. Fetal cardiac morphometry and function were assessed by echocardiography using 2Dimaging, M-mode and conventional Doppler. Results were evaluated by multivariate regression analysis. Results: Both groups had similar baseline characteristics. Recipients and donors showed an improvement in fetal cardiac systolic function with no significant differences with controls regarding cardiac output, ejection and shortening fraction. Diastolic parameters were similar in the three groups. However, longitudinal motion remained lower in recipients and donors when compared to controls: tricuspid annular systolic displacement (mm): 6,51±1,01 vs 6,18±0,82 vs 6,88 ±0,85; mital annular systolic displacement (mm) 4,72±0,72 vs 4,45±0,65 vs 5,18±0,78 p<0,001) and myocardial performance index (MPI) was higher in recipients and donors compared to controls (PI 0,48±0,10 vs 0,45±0,08 vs 0,43±0,07 p < 0,01).
Recipients showed cardiac remodelling at diagnosis, that persisted in the third trimester: Cardiothoracic ratio: 0,29±0,04 vs 0,27±0,03 vs 0,26±0,02 p<0,001; mean septal thickness (mm):4,22±0,37 vs 3,71±0,42 vs 3,62±0,34 p< 0,01). Conclusions: Fetal therapy is associated with prenatally improvement in cardiac function in recipients and donors. However, at third trimester there is still longitudinal motion abnormality in both fetuses and cardiac remodelling in the recipient. Postnatal cardiovascular evaluation is required to assess the clinical value of these findings. According to Czech National Guidelines (Recommendation of National OB/GYN society), in the Czech Republic, all pregnant women in their 1st trimester undergo red blood cell antibody screening. The screening is positive in about 5% of women (5000 women/year in the Czech Republic), but only in about 1.5% of them (1500 women/year) the clinically significant alloantibody is identified. However, the fetuses are at risk of hemolytic disease only if the complementary antigen is present on their erythrocytes. This is the case in about 0.5% of them (500 fetuses/year). The presence of the complementary antigen can be assessed noninvasively by genotyping from cell-free fetal DNA circulating in the peripheral blood of pregnant women. Severe hemolytic disease of the fetus that requires intrauterine blood transfusion up to the 35th week develops in only about 5-10% of them (25-50 fetuses/year). Severe fetal anemia can be predicted noninvasively by the Middle Cerebral Artery Peak Systolic Velocity measurement; therefore, cordocentesis should be performed only in these specific cases.
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